A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis
Status:
Completed
Trial end date:
2019-11-19
Target enrollment:
Participant gender:
Summary
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Methodology
Development Environmental Clinical Trial with Reproxalap Ophthalmic Solutions (0.25% and
0.5%) in Subjects with Seasonal Allergic Conjunctivitis.